首页 | 本学科首页   官方微博 | 高级检索  
     

冷冻联合光动力和腔内灌注化疗对恶性间皮瘤的疗效分析
引用本文:李海波,姚飞,曾健滢,陈继冰,李家亮,穆峰,牛立志,左建生,徐克成. 冷冻联合光动力和腔内灌注化疗对恶性间皮瘤的疗效分析[J]. 中华肺部疾病杂志(电子版), 2013, 6(4): 25-28
作者姓名:李海波  姚飞  曾健滢  陈继冰  李家亮  穆峰  牛立志  左建生  徐克成
作者单位:1. 中国科学院广州生物医药与健康研究院附属复大医院,广东广州,510665
2. 暨南大学医学院附属广州复大肿瘤医院,广东广州,510665
3. 510665广东广州,中国科学院广州生物医药与健康研究院附属复大医院;510665广东广州,暨南大学医学院附属广州复大肿瘤医院
摘    要:目的探讨冷冻联合光动力和腔内灌注化疗对恶性间皮瘤患者的疗效。方法对2003年9月至2012年6月广州复大医院收治的27例Ⅳ期恶性间皮瘤患者进行回顾性分析。全部患者治疗前都接受过化疗,化疗失败后来我院寻求进一步治疗。18例接受冷冻外科联合光动力和腔内化疗的患者为综合治疗组,9例只接受腔内灌注化疗的患者为姑息治疗组,评价两组患者的生存期差异,及治疗时机选择和治疗次数对患者生存期的影响。结果综合治疗组患者(中位生存64个月)的总体生存期显著长于姑息治疗组(中位生存9个月,P<0.001)。无论是综合治疗(多次治疗患者中位生存81.5个月,单次治疗患者中位生存38个月,P=0.0403)还是姑息治疗(多次治疗患者中位生存26.5个月,单次治疗患者中位生存7个月,P=0.037),多次治疗患者的生存期显著长于单次治疗。结论冷冻联合光动力和腔内灌注化疗可明显延长恶性间皮瘤患者全身化疗失败后的生存时间,多次治疗后患者生存时间可进一步延长。

关 键 词:间皮瘤,恶性  微创疗法  腔内灌注化疗

Effects of cryosurgery, photodynamic therapy and intracavity chemotherapy for the treatment of malignant mesothelima
LI Hai-bo;YAO Fei;ZENG Jian-ying;CHEN Ji-bing;LI Jia-liang;MU Feng;NIU Li-zhi;ZUO Jian-sheng;XU Ke-cheng. Effects of cryosurgery, photodynamic therapy and intracavity chemotherapy for the treatment of malignant mesothelima[J]. Chinese Journal of lung Disease(Electronic Edition), 2013, 6(4): 25-28
Authors:LI Hai-bo  YAO Fei  ZENG Jian-ying  CHEN Ji-bing  LI Jia-liang  MU Feng  NIU Li-zhi  ZUO Jian-sheng  XU Ke-cheng
Affiliation:LI Hai-bo1, YAO Fei2 , ZENG Jian-ying2 , CHEN Jr-brag , LI Jia-liang2 , MU Feng1 , NIU Li-zhi2 , ZUOJtan-sheng 12 , XU Ke_cheng12 ( 1 The GIHB Affiliated Fuda Hospital, Chinese Academy of Sciences, Guangzhou, 510665, China ; 2Jinan University Medical School Affiliated Guangzhou Fuda Cancer Hospital, Guangzhou, 510665, China)
Abstract:Objective To investigate multiple minimally invasive combination therapy (cryosurgery, photodynamie therapy and intracavity chemotherapy ) for the treatment of malignant mesothelioma patients in whom systemic chemotherapy had failed. Methods It was studied that of patients treated for malignant pleura] mesotheliona(MPM)or diffuse malignant pleura] mesotheliona(DMPM) in our cancer hospital from September 2003 to June 2012. 27 patients were divided into comprehensive (combination of the three therapies, 18 cases) and palliative (intraeavity ehemotherapy only, 9 cases) treatment groups. The interval survival for two group patients were assessed during a follow-up period. Result The overall survival of patients who received comprehensive treatment was significantly longer than that of those who received palliative treatment ( median overall survival: 64 vs. 9 months, P 〈 0. 001 ) and repeated treatments also prolonged the overall survival of patients than one time treatment, whatever comprehensive treatment (median overall survival: 81.5 vs. 38 months, P = 0. 0403 ) and palliative treatment ( median overall survival : 26.5 vs. 7 months, P = 0. 037 ). Conclusion Comprehensive treatments may have an advantage over palliative treatments for malignant mesothelioma patients in whom systemic chemotherapy had failed.
Keywords:Malignant mesothelioma  Minimally invasive surgery  Intracavity chemotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号